May 15, 2024

NHS offers life-saving drug

Tafamidis, also called vyndaqel and made by Pfizer, is the first drug for ATTR-CM that aims to treat the cause of the condition.

Experts say it should save lives, and trials suggest it can cut death risk by about 41%.

Read more – BBC Health (13/5/24)

Leave a Reply

Your email address will not be published. Required fields are marked *